HbO

Hemoglobin Oxygen Therapeutics LLC

Anti-N and anti-Do(a) immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.

Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW. Transfusion. 2019 Feb 15. doi: 10.1111/trf.15198. [Epub ahead of print] PubMed PMID: 30768787.